{
  "Version": 79,
  "Individuals": [
    {
      "Name": "human",
      "Seed": 1473890656,
      "OriginData": {
        "CalculationMethods": [
          "SurfaceAreaPlsInt_VAR1",
          "Body surface area - Mosteller"
        ],
        "Species": "Human",
        "Population": "European_ICRP_2002",
        "Gender": "MALE",
        "Age": {
          "Value": 30.0,
          "Unit": "year(s)"
        }
      },
      "ExpressionProfiles": []
    }
  ],
  "Compounds": [
    {
      "Name": "Tefibazumab",
      "IsSmallMolecule": false,
      "Lipophilicity": [
        {
          "Name": "Measurement",
          "Parameters": [
            {
              "Name": "Lipophilicity",
              "Value": -5.0,
              "Unit": "Log Units",
              "ValueOrigin": {
                "Source": "Other",
                "Description": "/Dummy value not used in the simulation"
              }
            }
          ]
        }
      ],
      "FractionUnbound": [
        {
          "Name": "Measurement",
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 1.0,
              "ValueOrigin": {
                "Source": "Other",
                "Description": "Assumption"
              }
            }
          ]
        }
      ],
      "Solubility": [
        {
          "Name": "Measurement",
          "Parameters": [
            {
              "Name": "Solubility at reference pH",
              "Value": 9999.0,
              "Unit": "mg/l",
              "ValueOrigin": {
                "Source": "Other",
                "Description": "/Dummy value not used in the simulation"
              }
            },
            {
              "Name": "Reference pH",
              "Value": 7.0,
              "ValueOrigin": {
                "Source": "Other",
                "Description": "/Dummy value not used in the simulation"
              }
            }
          ]
        }
      ],
      "CalculationMethods": [
        "Cellular partition coefficient method - PK-Sim Standard",
        "Cellular permeability - PK-Sim Standard"
      ],
      "Parameters": [
        {
          "Name": "Molecular weight",
          "Value": 150000.0,
          "Unit": "g/mol",
          "ValueOrigin": {
            "Source": "Publication",
            "Description": "Lobo2004"
          }
        },
        {
          "Name": "Radius (solute)",
          "Value": 0.00534,
          "Unit": "µm",
          "ValueOrigin": {
            "Id": 26,
            "Source": "Publication",
            "Description": "Taylor1984"
          }
        },
        {
          "Name": "Kd (FcRn) in endosomal space",
          "Value": 0.85,
          "Unit": "µmol/l",
          "ValueOrigin": {
            "Id": 26,
            "Source": "ParameterIdentification"
          }
        }
      ]
    },
    {
      "Name": "Tefibazumab__Kd_Zhou2003",
      "IsSmallMolecule": false,
      "Lipophilicity": [
        {
          "Name": "Measurement",
          "Parameters": [
            {
              "Name": "Lipophilicity",
              "Value": -5.0,
              "Unit": "Log Units",
              "ValueOrigin": {
                "Source": "Other",
                "Description": "/Dummy value not used in the simulation"
              }
            }
          ]
        }
      ],
      "FractionUnbound": [
        {
          "Name": "Measurement",
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 1.0,
              "ValueOrigin": {
                "Source": "Other",
                "Description": "Assumption"
              }
            }
          ]
        }
      ],
      "Solubility": [
        {
          "Name": "Measurement",
          "Parameters": [
            {
              "Name": "Solubility at reference pH",
              "Value": 9999.0,
              "Unit": "mg/l",
              "ValueOrigin": {
                "Source": "Other",
                "Description": "/Dummy value not used in the simulation"
              }
            },
            {
              "Name": "Reference pH",
              "Value": 7.0,
              "ValueOrigin": {
                "Source": "Other",
                "Description": "/Dummy value not used in the simulation"
              }
            }
          ]
        }
      ],
      "CalculationMethods": [
        "Cellular partition coefficient method - PK-Sim Standard",
        "Cellular permeability - PK-Sim Standard"
      ],
      "Parameters": [
        {
          "Name": "Molecular weight",
          "Value": 150000.0,
          "Unit": "g/mol",
          "ValueOrigin": {
            "Source": "Publication",
            "Description": "Lobo2004"
          }
        },
        {
          "Name": "Radius (solute)",
          "Value": 0.00534,
          "Unit": "µm",
          "ValueOrigin": {
            "Id": 26,
            "Source": "Publication",
            "Description": "Taylor1984"
          }
        },
        {
          "Name": "Kd (FcRn) in endosomal space",
          "Value": 0.63,
          "Unit": "µmol/l",
          "ValueOrigin": {
            "Id": 26,
            "Source": "Publication",
            "Description": "Zhou2003"
          }
        }
      ]
    }
  ],
  "Protocols": [
    {
      "Name": "IV_2mgkg",
      "ApplicationType": "Intravenous",
      "DosingInterval": "Single",
      "Parameters": [
        {
          "Name": "Start time",
          "Value": 0.0,
          "Unit": "h"
        },
        {
          "Name": "InputDose",
          "Value": 2.0,
          "Unit": "mg/kg"
        },
        {
          "Name": "Infusion time",
          "Value": 15.0,
          "Unit": "min"
        }
      ]
    },
    {
      "Name": "IV_5mgkg",
      "ApplicationType": "Intravenous",
      "DosingInterval": "Single",
      "Parameters": [
        {
          "Name": "Start time",
          "Value": 0.0,
          "Unit": "h"
        },
        {
          "Name": "InputDose",
          "Value": 5.0,
          "Unit": "mg/kg"
        },
        {
          "Name": "Infusion time",
          "Value": 15.0,
          "Unit": "min"
        }
      ]
    },
    {
      "Name": "IV_10mgkg",
      "ApplicationType": "Intravenous",
      "DosingInterval": "Single",
      "Parameters": [
        {
          "Name": "Start time",
          "Value": 0.0,
          "Unit": "h"
        },
        {
          "Name": "InputDose",
          "Value": 10.0,
          "Unit": "mg/kg"
        },
        {
          "Name": "Infusion time",
          "Value": 15.0,
          "Unit": "min"
        }
      ]
    },
    {
      "Name": "IV_20mgkg",
      "ApplicationType": "Intravenous",
      "DosingInterval": "Single",
      "Parameters": [
        {
          "Name": "Start time",
          "Value": 0.0,
          "Unit": "h"
        },
        {
          "Name": "InputDose",
          "Value": 20.0,
          "Unit": "mg/kg"
        },
        {
          "Name": "Infusion time",
          "Value": 15.0,
          "Unit": "min"
        }
      ]
    }
  ],
  "Simulations": [
    {
      "Name": "Tefibazumab_2mgkg_Kd_Zhou2003",
      "Model": "TwoPores",
      "ObservedData": [
        "Reilley2005_tefibazumab_PKSimImport.Dose2"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 56.0,
              "Unit": "day(s)",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|IV_2mgkg|Application_1|ProtocolSchemaItem|Infusion time",
          "Value": 15.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Tefibazumab__Kd_Zhou2003|Plasma (Peripheral Venous Blood)"
      ],
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Tefibazumab_2mgkg_Kd_Zhou2003|Organism|PeripheralVenousBlood|Tefibazumab__Kd_Zhou2003|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Reilley2005_tefibazumab_PKSimImport.Dose2"
        }
      ],
      "Individual": "human",
      "Compounds": [
        {
          "Name": "Tefibazumab__Kd_Zhou2003",
          "CalculationMethods": [
            "Cellular partition coefficient method - PK-Sim Standard",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Protocol": {
            "Name": "IV_2mgkg"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "day(s)",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Tefibazumab__Kd_Zhou2003-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Tefibazumab_2mgkg_Kd_Zhou2003|Organism|PeripheralVenousBlood|Tefibazumab__Kd_Zhou2003|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Reilley2005_tefibazumab_PKSimImport.Dose2-Tefibazumab-Peripheral Venous Blood-Plasma-Measurement",
              "X": "Reilley2005_tefibazumab_PKSimImport.Dose2|Time",
              "Y": "Reilley2005_tefibazumab_PKSimImport.Dose2|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Tefibazumab\nTefibazumab_2mgkg_Kd_Zhou2003\n2023-03-07 10:07"
        }
      ]
    },
    {
      "Name": "Tefibazumab_5mgkg_Kd_Zhou2003",
      "Model": "TwoPores",
      "ObservedData": [
        "Reilley2005_tefibazumab_PKSimImport.Dose5"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 56.0,
              "Unit": "day(s)",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|IV_5mgkg|Application_1|ProtocolSchemaItem|Infusion time",
          "Value": 15.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Tefibazumab__Kd_Zhou2003|Plasma (Peripheral Venous Blood)"
      ],
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Tefibazumab_5mgkg_Kd_Zhou2003|Organism|PeripheralVenousBlood|Tefibazumab__Kd_Zhou2003|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Reilley2005_tefibazumab_PKSimImport.Dose5"
        }
      ],
      "Individual": "human",
      "Compounds": [
        {
          "Name": "Tefibazumab__Kd_Zhou2003",
          "CalculationMethods": [
            "Cellular partition coefficient method - PK-Sim Standard",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Protocol": {
            "Name": "IV_5mgkg"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "day(s)",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Tefibazumab__Kd_Zhou2003-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Tefibazumab_5mgkg_Kd_Zhou2003|Organism|PeripheralVenousBlood|Tefibazumab__Kd_Zhou2003|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Reilley2005_tefibazumab_PKSimImport.Dose5-Tefibazumab-Peripheral Venous Blood-Plasma-Measurement",
              "X": "Reilley2005_tefibazumab_PKSimImport.Dose5|Time",
              "Y": "Reilley2005_tefibazumab_PKSimImport.Dose5|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Tefibazumab\nTefibazumab_5mgkg_Kd_Zhou2003\n2023-03-07 10:07"
        }
      ]
    },
    {
      "Name": "Tefibazumab_10mgkg_Kd_Zhou2003",
      "Model": "TwoPores",
      "ObservedData": [
        "Reilley2005_tefibazumab_PKSimImport.Dose10"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 56.0,
              "Unit": "day(s)",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|IV_10mgkg|Application_1|ProtocolSchemaItem|Infusion time",
          "Value": 15.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Tefibazumab__Kd_Zhou2003|Plasma (Peripheral Venous Blood)"
      ],
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Tefibazumab_10mgkg_Kd_Zhou2003|Organism|PeripheralVenousBlood|Tefibazumab__Kd_Zhou2003|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Reilley2005_tefibazumab_PKSimImport.Dose10"
        }
      ],
      "Individual": "human",
      "Compounds": [
        {
          "Name": "Tefibazumab__Kd_Zhou2003",
          "CalculationMethods": [
            "Cellular partition coefficient method - PK-Sim Standard",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Protocol": {
            "Name": "IV_10mgkg"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "day(s)",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Tefibazumab__Kd_Zhou2003-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Tefibazumab_10mgkg_Kd_Zhou2003|Organism|PeripheralVenousBlood|Tefibazumab__Kd_Zhou2003|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Reilley2005_tefibazumab_PKSimImport.Dose10-Tefibazumab-Peripheral Venous Blood-Plasma-Measurement",
              "X": "Reilley2005_tefibazumab_PKSimImport.Dose10|Time",
              "Y": "Reilley2005_tefibazumab_PKSimImport.Dose10|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Tefibazumab\nTefibazumab_10mgkg_Kd_Zhou2003\n2023-03-07 10:07"
        }
      ]
    },
    {
      "Name": "Tefibazumab_20mgkg_Kd_Zhou2003",
      "Model": "TwoPores",
      "ObservedData": [
        "Reilley2005_tefibazumab_PKSimImport.Dose20"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 56.0,
              "Unit": "day(s)",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|IV_20mgkg|Application_1|ProtocolSchemaItem|Infusion time",
          "Value": 15.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Tefibazumab__Kd_Zhou2003|Plasma (Peripheral Venous Blood)"
      ],
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Tefibazumab_20mgkg_Kd_Zhou2003|Organism|PeripheralVenousBlood|Tefibazumab__Kd_Zhou2003|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Reilley2005_tefibazumab_PKSimImport.Dose20"
        }
      ],
      "Individual": "human",
      "Compounds": [
        {
          "Name": "Tefibazumab__Kd_Zhou2003",
          "CalculationMethods": [
            "Cellular partition coefficient method - PK-Sim Standard",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Protocol": {
            "Name": "IV_20mgkg"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "day(s)",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Tefibazumab__Kd_Zhou2003-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Tefibazumab_20mgkg_Kd_Zhou2003|Organism|PeripheralVenousBlood|Tefibazumab__Kd_Zhou2003|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Reilley2005_tefibazumab_PKSimImport.Dose20-Tefibazumab-Peripheral Venous Blood-Plasma-Measurement",
              "X": "Reilley2005_tefibazumab_PKSimImport.Dose20|Time",
              "Y": "Reilley2005_tefibazumab_PKSimImport.Dose20|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Tefibazumab\nTefibazumab_20mgkg_Kd_Zhou2003\n2023-03-07 10:07"
        }
      ]
    },
    {
      "Name": "Tefibazumab_10mgkg_Kd_fit",
      "Model": "TwoPores",
      "ObservedData": [
        "Reilley2005_tefibazumab_PKSimImport.Dose10"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 56.0,
              "Unit": "day(s)",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|IV_10mgkg|Application_1|ProtocolSchemaItem|Infusion time",
          "Value": 15.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)"
      ],
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Tefibazumab_10mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Reilley2005_tefibazumab_PKSimImport.Dose10"
        }
      ],
      "Individual": "human",
      "Compounds": [
        {
          "Name": "Tefibazumab",
          "CalculationMethods": [
            "Cellular partition coefficient method - PK-Sim Standard",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Protocol": {
            "Name": "IV_10mgkg"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "day(s)",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Tefibazumab-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Tefibazumab_10mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Reilley2005_tefibazumab_Dose 10 mg/kg",
              "X": "Reilley2005_tefibazumab_PKSimImport.Dose10|Time",
              "Y": "Reilley2005_tefibazumab_PKSimImport.Dose10|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Plasma concentration - 10 mg/kg dose (linear scale)",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Tefibazumab\nTefibazumab_10mgkg_Kd_fit\n2023-03-07 10:08"
        },
        {
          "Axes": [
            {
              "Unit": "day(s)",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Tefibazumab-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Tefibazumab_10mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Reilley2005_tefibazumab_Dose 10 mg/kg",
              "X": "Reilley2005_tefibazumab_PKSimImport.Dose10|Time",
              "Y": "Reilley2005_tefibazumab_PKSimImport.Dose10|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Plasma concentration - 10 mg/kg dose (log scale)",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#00FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Tefibazumab\nTefibazumab_10mgkg_Kd_fit\n2023-03-07 10:08"
        }
      ]
    },
    {
      "Name": "Tefibazumab_20mgkg_Kd_fit",
      "Model": "TwoPores",
      "ObservedData": [
        "Reilley2005_tefibazumab_PKSimImport.Dose20"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 56.0,
              "Unit": "day(s)",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|IV_20mgkg|Application_1|ProtocolSchemaItem|Infusion time",
          "Value": 15.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)"
      ],
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Tefibazumab_20mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Reilley2005_tefibazumab_PKSimImport.Dose20"
        }
      ],
      "Individual": "human",
      "Compounds": [
        {
          "Name": "Tefibazumab",
          "CalculationMethods": [
            "Cellular partition coefficient method - PK-Sim Standard",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Protocol": {
            "Name": "IV_20mgkg"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "day(s)",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Tefibazumab-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Tefibazumab_20mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Reilley2005_tefibazumab_Dose 20 mg/kg",
              "X": "Reilley2005_tefibazumab_PKSimImport.Dose20|Time",
              "Y": "Reilley2005_tefibazumab_PKSimImport.Dose20|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Plasma concentration - 20 mg/kg dose (linear scale)",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Tefibazumab\nTefibazumab_20mgkg_Kd_fit\n2023-03-07 10:08"
        },
        {
          "Axes": [
            {
              "Unit": "day(s)",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Tefibazumab-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Tefibazumab_20mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Reilley2005_tefibazumab_Dose 20 mg/kg",
              "X": "Reilley2005_tefibazumab_PKSimImport.Dose20|Time",
              "Y": "Reilley2005_tefibazumab_PKSimImport.Dose20|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Plasma concentration - 20 mg/kg dose (log scale)",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#00FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Tefibazumab\nTefibazumab_20mgkg_Kd_fit\n2023-03-07 10:08"
        }
      ]
    },
    {
      "Name": "Tefibazumab_2mgkg_Kd_fit",
      "Model": "TwoPores",
      "ObservedData": [
        "Reilley2005_tefibazumab_PKSimImport.Dose2"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 56.0,
              "Unit": "day(s)",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|IV_2mgkg|Application_1|ProtocolSchemaItem|Infusion time",
          "Value": 15.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)"
      ],
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Tefibazumab_2mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Reilley2005_tefibazumab_PKSimImport.Dose2"
        }
      ],
      "Individual": "human",
      "Compounds": [
        {
          "Name": "Tefibazumab",
          "CalculationMethods": [
            "Cellular partition coefficient method - PK-Sim Standard",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Protocol": {
            "Name": "IV_2mgkg"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "day(s)",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Tefibazumab-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Tefibazumab_2mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Reilley2005_tefibazumab_Dose 2 mg/kg",
              "X": "Reilley2005_tefibazumab_PKSimImport.Dose2|Time",
              "Y": "Reilley2005_tefibazumab_PKSimImport.Dose2|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Plasma concentration - 2 mg/kg dose (linear scale)",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Tefibazumab\nTefibazumab_2mgkg_Kd_fit\n2023-03-07 10:08"
        },
        {
          "Axes": [
            {
              "Unit": "day(s)",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Tefibazumab-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Tefibazumab_2mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Reilley2005_tefibazumab_Dose 2 mg/kg",
              "X": "Reilley2005_tefibazumab_PKSimImport.Dose2|Time",
              "Y": "Reilley2005_tefibazumab_PKSimImport.Dose2|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Plasma concentration - 2 mg/kg dose (log scale)",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#00FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Tefibazumab\nTefibazumab_2mgkg_Kd_fit\n2023-03-07 10:08"
        }
      ]
    },
    {
      "Name": "Tefibazumab_5mgkg_Kd_fit",
      "Model": "TwoPores",
      "ObservedData": [
        "Reilley2005_tefibazumab_PKSimImport.Dose5"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 56.0,
              "Unit": "day(s)",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|IV_5mgkg|Application_1|ProtocolSchemaItem|Infusion time",
          "Value": 15.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)"
      ],
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Tefibazumab_5mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Reilley2005_tefibazumab_PKSimImport.Dose5"
        }
      ],
      "Individual": "human",
      "Compounds": [
        {
          "Name": "Tefibazumab",
          "CalculationMethods": [
            "Cellular partition coefficient method - PK-Sim Standard",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Protocol": {
            "Name": "IV_5mgkg"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "day(s)",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Tefibazumab-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Tefibazumab_5mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Reilley2005_tefibazumab_Dose 5 mg/kg",
              "X": "Reilley2005_tefibazumab_PKSimImport.Dose5|Time",
              "Y": "Reilley2005_tefibazumab_PKSimImport.Dose5|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Plasma concentration - 5 mg/kg dose (linear scale)",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Tefibazumab\nTefibazumab_5mgkg_Kd_fit\n2023-03-07 10:08"
        },
        {
          "Axes": [
            {
              "Unit": "day(s)",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Tefibazumab-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Tefibazumab_5mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Reilley2005_tefibazumab_Dose 5 mg/kg",
              "X": "Reilley2005_tefibazumab_PKSimImport.Dose5|Time",
              "Y": "Reilley2005_tefibazumab_PKSimImport.Dose5|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Plasma concentration - 5 mg/kg dose (log scale)",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "RightInside",
            "BackColor": "#00FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Tefibazumab\nTefibazumab_5mgkg_Kd_fit\n2023-03-07 10:08"
        }
      ]
    }
  ],
  "ObservedData": [
    {
      "Name": "Reilley2005_tefibazumab_PKSimImport.Dose10",
      "ExtendedProperties": [
        {
          "Name": "Sheet",
          "Value": "PKSimImport"
        },
        {
          "Name": "Molecule",
          "Value": "Tefibazumab"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Dose [mg/kg]",
          "Value": "10"
        }
      ],
      "Columns": [
        {
          "Name": "Measurement",
          "RelatedColumns": [
            {
              "Name": "Error",
              "QuantityInfo": {
                "Path": "Reilley2005_tefibazumab_PKSimImport.Dose10|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Error"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "MolWeight": 150000.0
              },
              "Values": [
                33.5069427,
                0.0,
                18.15605,
                12.1332092,
                11.84412,
                12.27577,
                7.483139,
                8.541084,
                5.73546171,
                3.84905982,
                4.810568,
                3.301664
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "µg/ml"
            }
          ],
          "QuantityInfo": {
            "Path": "Reilley2005_tefibazumab_PKSimImport.Dose10|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 150000.0
          },
          "Values": [
            247.739685,
            215.7307,
            187.8599,
            169.3571,
            140.87941,
            127.0168,
            104.4699,
            69.87489,
            52.4493179,
            39.82602,
            25.4736214,
            16.29371
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Reilley2005_tefibazumab_PKSimImport.Dose10|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          0.0520833321,
          0.25,
          0.5,
          1.0,
          3.0,
          4.0,
          7.0,
          14.0,
          21.0,
          28.0,
          42.0,
          56.0
        ],
        "Dimension": "Time",
        "Unit": "day(s)"
      }
    },
    {
      "Name": "Reilley2005_tefibazumab_PKSimImport.Dose2",
      "ExtendedProperties": [
        {
          "Name": "Sheet",
          "Value": "PKSimImport"
        },
        {
          "Name": "Molecule",
          "Value": "Tefibazumab"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Dose [mg/kg]",
          "Value": "2"
        }
      ],
      "Columns": [
        {
          "Name": "Measurement",
          "RelatedColumns": [
            {
              "Name": "Error",
              "QuantityInfo": {
                "Path": "Reilley2005_tefibazumab_PKSimImport.Dose2|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Error"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "MolWeight": 150000.0
              },
              "Values": [
                5.664219,
                6.684361,
                4.82092333,
                5.270298,
                15.1014805,
                3.58954215,
                3.304609,
                2.451799,
                2.92109513,
                4.44645834,
                3.60513115,
                3.0141108
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "µg/ml"
            }
          ],
          "QuantityInfo": {
            "Path": "Reilley2005_tefibazumab_PKSimImport.Dose2|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 150000.0
          },
          "Values": [
            58.60735,
            54.69136,
            49.87463,
            48.18296,
            39.62135,
            29.36267,
            24.4306,
            18.12777,
            14.41449,
            13.94464,
            8.616008,
            6.256439
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Reilley2005_tefibazumab_PKSimImport.Dose2|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          0.0520833321,
          0.25,
          0.5,
          1.0,
          3.0,
          4.0,
          7.0,
          14.0,
          21.0,
          28.0,
          42.0,
          56.0
        ],
        "Dimension": "Time",
        "Unit": "day(s)"
      }
    },
    {
      "Name": "Reilley2005_tefibazumab_PKSimImport.Dose20",
      "ExtendedProperties": [
        {
          "Name": "Sheet",
          "Value": "PKSimImport"
        },
        {
          "Name": "Molecule",
          "Value": "Tefibazumab"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Dose [mg/kg]",
          "Value": "20"
        }
      ],
      "Columns": [
        {
          "Name": "Measurement",
          "RelatedColumns": [
            {
              "Name": "Error",
              "QuantityInfo": {
                "Path": "Reilley2005_tefibazumab_PKSimImport.Dose20|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Error"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "MolWeight": 150000.0
              },
              "Values": [
                72.59933,
                0.0,
                43.29471,
                53.46899,
                29.6064816,
                29.53885,
                0.0,
                10.5779295,
                0.0,
                7.90149736,
                12.16108,
                7.60672
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "µg/ml"
            }
          ],
          "QuantityInfo": {
            "Path": "Reilley2005_tefibazumab_PKSimImport.Dose20|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 150000.0
          },
          "Values": [
            489.2018,
            451.2802,
            397.5311,
            384.057281,
            271.8462,
            247.939285,
            196.9903,
            136.3971,
            92.28877,
            72.54391,
            50.30176,
            30.37143
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Reilley2005_tefibazumab_PKSimImport.Dose20|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          0.0520833321,
          0.25,
          0.5,
          1.0,
          3.0,
          4.0,
          7.0,
          14.0,
          21.0,
          28.0,
          42.0,
          56.0
        ],
        "Dimension": "Time",
        "Unit": "day(s)"
      }
    },
    {
      "Name": "Reilley2005_tefibazumab_PKSimImport.Dose5",
      "ExtendedProperties": [
        {
          "Name": "Sheet",
          "Value": "PKSimImport"
        },
        {
          "Name": "Molecule",
          "Value": "Tefibazumab"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Dose [mg/kg]",
          "Value": "5"
        }
      ],
      "Columns": [
        {
          "Name": "Measurement",
          "RelatedColumns": [
            {
              "Name": "Error",
              "QuantityInfo": {
                "Path": "Reilley2005_tefibazumab_PKSimImport.Dose5|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Error"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "MolWeight": 150000.0
              },
              "Values": [
                5.593964,
                8.782104,
                14.43988,
                11.9027195,
                4.487007,
                4.771439,
                3.44371,
                2.497547,
                3.112619,
                2.264486,
                1.913603,
                1.47936392
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "µg/ml"
            }
          ],
          "QuantityInfo": {
            "Path": "Reilley2005_tefibazumab_PKSimImport.Dose5|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 150000.0
          },
          "Values": [
            124.019295,
            122.605095,
            106.7641,
            97.36496,
            75.57823,
            66.5876541,
            58.01839,
            42.06819,
            28.4641,
            23.43058,
            14.14702,
            9.92328548
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Reilley2005_tefibazumab_PKSimImport.Dose5|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          0.0520833321,
          0.25,
          0.5,
          1.0,
          3.0,
          4.0,
          7.0,
          14.0,
          21.0,
          28.0,
          42.0,
          56.0
        ],
        "Dimension": "Time",
        "Unit": "day(s)"
      }
    }
  ],
  "SimulationClassifications": [
    {
      "Name": "Kd_Zhou2003",
      "Classifiables": [
        "Tefibazumab_10mgkg_Kd_Zhou2003",
        "Tefibazumab_20mgkg_Kd_Zhou2003",
        "Tefibazumab_2mgkg_Kd_Zhou2003",
        "Tefibazumab_5mgkg_Kd_Zhou2003"
      ]
    },
    {
      "Name": "Kd_fit",
      "Classifiables": [
        "Tefibazumab_10mgkg_Kd_fit",
        "Tefibazumab_20mgkg_Kd_fit",
        "Tefibazumab_2mgkg_Kd_fit",
        "Tefibazumab_5mgkg_Kd_fit"
      ]
    }
  ]
}